This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when ...

The clinical features, etiology, and treatment of recurrent aphthous ulcers (RAU) are discussed. Aphthous ulcers are among the most common oral lesions in the general population, with a frequency ...

Recurrent aphthous ulcer (RAU) is the most prevalent oral mucosal disease in humans, estimated to affect between 5% and 50% of the general population. The minor manifestation of the condition is ...

They usually resolve within 10 to 14 days, but often recur. Recurrent aphthous ulcers affect about 1 in 5 people. Specific ...

Biopsies of active lesions revealed ulceration with neutrophil-rich ... reduced disease activity in treatment-refractory recurrent aphthous stomatitis. The small number of patients and ...

The clinical appearance and histopathologic features of the ulcers were consistent with aphthous stomatitis ... The patient continues to take pentoxifylline for recurrent ulceration.

Stomatitis that reoccurs and includes mouth ulcers is called recurrent aphthous stomatitis (RAS) and is the most common disease affecting the mouth area, with around 5-25 percent of the United ...

On the other hand, some studies suggest cannabis could be beneficial for ulcer management. For example, a 2023 trial tested topical cannabidiol (CBD) for recurrent aphthous ulcers (canker sores).

Background: Chronic recurrent oral aphthous ulcers are the most common type of inflammatory efflorescence of the oral mucosa, with a prevalence of 2% to 10% in Caucasian populations. To treat them ...